11:53 AM EST - Ventripoint Diagnostics Ltd. : announced that it has submitted to the U.S. Federal Drug Administration a new 510(k) for clearance for the VMS™ heart analysis system for use in Pulmonary Arterial Hypertension. Ventripoint Diagnostics Ltd.
shares V.VPT are trading unchanged at $0.09.
